X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Perceptive Advisors LLC reported a 8.10% stake in X4 Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Perceptive Advisors LLC reported a 8.10% stake in X4 Pharmaceuticals, Inc., 8,085,006 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 8.10%
- Shares
- 8,085,006
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 8.10% | 8,085,006 |
| Joseph Edelman | 8.10% | 8,085,006 |
| Perceptive Life Sciences Master Fund, Ltd. | 8.10% | 8,085,006 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Perceptive Advisors LLC
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G · Perceptive Advisors LLC · Nov 3, 2025
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026